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There is an established consensus that it is primarily the adaptive arm of immunity, and the T cell subset in
particular, that is most susceptible to the deleterious changes with age known as “immunosenescence”. Can we
garner any clues as to why this might be by considering comparative immunology and the evolutionary
emergence of adaptive and innate immunity? The immune system is assumed to have evolved to protect the
organism against pathogens, but the way in which this is accomplished is different in the innate-vs-adaptive arms,
and it is unclear why the latter is necessary. Are there special characteristics of adaptive immunity which might
make the system more susceptible to age-associated dysfunction? Given recent accumulating findings that actually
there are age-associated changes to innate immunity and that these are broadly similar in vertebrates and
invertebrates, we suggest here that it is the special property of memory in the adaptive immune system which
results in the accumulation of cells with a restricted receptor repertoire, dependent on the immunological history
of the individual’s exposures to pathogens over the lifetime, and which is commonly taken as a hallmark of
“immunosenescence”. However, we further hypothesize that this immunological remodelling per se does not
necessarily convey a disadvantage to the individual (ie. is not necessarily “senescence” if it is not deleterious).
Indeed, under certain circumstances, or potentially even as a rule, this adaptation to the individual host
environment may confer an actual survival advantage.Introduction
The vertebrate immune system evolved to maintain
homeostatic balance between host tissues and the in-
ternal and external microbiological environment in order
to assure the integrity of the host and possibly the
microbiome (ie. the gut microbiota). In all multi-cellular
organisms, both vertebrate and invertebrate, soluble fac-
tors are produced which protect against bacterial, viral
and fungal invasion. In addition, in most animals, special-
ized cells developed which are dedicated to rapid recogni-
tion and elimination of pathogens by means of specific
cell surface receptors (Figure 1) recognizing molecular en-
tities such as pathogen-associated molecular patterns
(PAMPs) shared by invaders but absent from the host.
This system is referred to as innate, non-clonotypic im-
munity. Only in vertebrates (Figure 2), another class of
cells emerged which recognize microorganisms by means* Correspondence: lmueller@mpib-berlin.mpg.de
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reproduction in any medium, provided the orof unique clonotypic receptors formed by recombination
of highly diverse genetic modules to generate a very large
repertoire of different antigen-recognizing molecules. On
contact with their targets, these cells must undergo exten-
sive clonal expansion and differentiation into effector cells
in order to generate sufficient numbers of cells to success-
fully combat the invader. Thereafter, excess effector cells
must be eliminated in a controlled manner by apoptosis,
but a fraction of greatly varying size must be retained as
memory cells to mediate a more rapid specific response
on re-exposure to the same pathogen. Hence this arm of
immunity is designated “adaptive”. Clearly, as the space
available in the body is finite, there must be a limit to the
amount of memory cells-vs-naïve cells that can be usefully
maintained without overt leukocytosis. This is the theory
of the restricted “immunological space” contributing to
age-associated changes to immunity [1]. In most verte-
brates, the receptors of the adaptive arm of immunity be-
long to the immunoglobulin family, expressed on the two
main types of lymphocytes, B cells and T cells. Fascinat-
ingly, in the few known surviving jawless vertebrates, the
same division of labour is observed, and recently even aLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and















Figure 1 Innate immune responses are elicited by ligation of specific cell surface receptors (for instance, TLR) recognizing molecular
entities (PAMP and MAMP) shared by invaders, such as bacteria, viruses and fungi, but absent from the host. PAMP: pathogen-associated
molecular patterns; MAMP: microbe-associated molecular patterns; TLR: toll-like receptor.
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but both the cell types and the genes for their clonotypic
receptors are completely different (reviewed in [3]). This
presumably represents an interesting case of evolutionary
convergence and underscores the basic importance to all
vertebrates of this dual type of adaptive immunity. None-
theless, it remains a puzzle as to why invertebrates, which
can be large and complex and often share the same exter-
nal environment as vertebrates, seem able to protect
themselves perfectly well against pathogenic microorgan-
isms using innate immunity, whereas all vertebrates make
what amounts to a considerable investment of resources
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Figure 2 Immune response in vertebrates to pathogens. TC: T cells; CTadaptive immune systems, using two completely different
“tool kits”. An intriguing emerging theory to explain this
posits that vertebrates have co-opted a much larger range
of gut bacteria than invertebrates commonly have, in
order to increase efficacy of nutrient processing. As innate
immunity recognizes both beneficial and pathogenic mi-
croorganisms equally well via microbe-specific pattern re-
ceptors, it can be hypothesized that adaptive immunity
arose to help distinguish between the two by regulating in-
nate immunity and targeting specific antigens derived
from pathogens but not from symbionts [4]. This implies
that adaptive immunity must be able to deal with a much









L: cytotoxic T lymphocytes.
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relative importance to the former.
Here, we will briefly review some of what is known about
age-related changes to innate immunity in experimental
models and in humans, and to adaptive immunity in higher
animals, most particularly humans. It may be instructive to
consider examples of invertebrates, which possess solely
humoural innate defences (selecting C. elegans as the best,
albeit still very superficially, investigated), then inverte-
brates with both cellular and humoural innate immunity
(mostly Drosophila) and finally vertebrates possessing both
innate and adaptive immunity (focussing on humans,
except where reference must be made to another well-
studied species: the mouse).
Invertebrates
C. elegans
Many basic lessons can be learned from the worm
(Figure 3). First and foremost, strikingly, innate immune
signalling pathways in C. elegans are intimately linked
with ageing. In particular, the DAF-2 pathway is crucial
for resistance to bacterial infection at the same time as
being central to longevity determination [5-8]. Thus, older
worms show increasing susceptibility to infection, and
longer-lived DAF mutants are more resistant. In this
model, it is possible to study purely humoural innate im-
munity, as no cell-mediated defences have been identified,
reducing complexity of the analysis. The phylogenetically-
widespread Toll-like receptors commonly employed by
other invertebrates as well as mammals to recognize mi-
crobial products are also absent in worms, as is the con-
served NF-κB transcription factor family, central to












Figure 3 Immune signalling pathways in C. elegans are linked
with ageing. DAF-2: insulin/insulin growth factor-1-like receptor;
DAF-16: forkhead transcriptional factor; MAPK-1: mitogen-activated
protein kinase 1.offers a simplified system for studying some aspects of im-
munity, without the confounding factors present in other
models. Nonetheless, recent findings suggest that even C.
elegans may possess some elements of immune memory,
implying a central requirement for sophisticated immunity
for survival even within such (relatively) simple systems.
Thus, worms surviving exposure to a pathogen are able to
survive re-exposure to doses of that pathogen which
would otherwise have proven fatal. This ability is a central
feature of adaptive immunity in higher organisms. How is
this possible in the worm? It seems that the association
between neurological and immune memory may already
have emerged at the evolutionary stage of nematode de-
velopment (Figure 3). Anyanful et al. found that this type
of “immune memory” depended on the integrity of dopa-
minergic neurons, as well as signalling pathways crucial
for longevity, such as DAF-2 and the p38 MAPK-like
stress-resistance pathway regulating innate immunity [9].
Nonetheless, recent data show that ageing and innate im-
munity are regulated by distinct genetic mechanisms,
confirming overlap but not identity in their genetic con-
trol [10]. The message from the worm, nonetheless, is
clearly that immunity and aging are closely linked, not
only via prevention of death due to infections [7,11].
D. melanogaster
In addition to humoural immunity, like other insects as
well as numerous other invertebrates, D. melanogaster
(Figure 4) possesses cellular effectors expressing micro-
bial pattern recognition receptors [12]. There are two
main signalling pathways, designated Toll and IMD, both
converging on NF-κB family transcription factors, which
drive transcription of genes encoding anti-microbial pep-
tides. The NF-κB family as a central regulatory complex is
conserved throughout the higher metazoans; thus, unlike
the innate pathways operative in C. elegans discussed
above, these pathways are highly conserved and are also
found in vertebrates. Similarly, a class of phagocytic cells
analogous to mammalian macrophages is also present in
insects (Figure 4) [13].
Despite the relative wealth of knowledge on insect im-
munity, surprisingly little is known about age-related
changes to immune competence. Levels of anti-microbial
peptides increase with age, and this has been associated
with a decrease in fecundity [14] but not lifespan [15].
However, linking ageing with oxidative stress, gene tran-
scription studies suggested that similar patterns of gene
expression changes were induced in young flies exposed
to oxidative stress as in old flies not otherwise stressed
[16]; many of the genes upregulated with age were related
to immune function [17]. More recently, infection models
have suggested that old flies have more trouble clearing
bacterial infections due to altered expression of genes in-
volved in energy metabolism and insulin signalling [18].
















Figure 4 Systemic immune response in Drosophila melanogaster.
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activity of haemocytes in older flies [19]. However, there
appears to be a great deal of heterogeneity between
different populations of Drosophila, with age affecting im-
munity negatively but also positively in some lines [20].
Thus, much remains to be learned in this relatively unex-
plored area of comparative immunogerontology.
Vertebrates
Vertebrates are unique in that in addition to retention of
innate immunity of the types found in invertebrates, they
also possess a sophisticated cellular and humoural im-
mune system (Figure 2) exploiting clonotypic antigen re-
ceptors and imbued with memory (so-called “adaptive
immunity”). They also possess other specialized cells that
are part of the innate system but act as a bridge to the
adaptive system and are not present in invertebrates. Thus,
these cells (especially the antigen-presenting cells, DC, or
NK cells) could also be responsible for age-associated de-
creased immunity in vertebrates; however, while changes
are recorded, they do not seem as extravagant as those
recorded for T and B cells (see following sections). Most
information that we have on the ageing immune system in
vertebrates derives from experimental studies in mice, with
limited data also available in other rodents, cats, dogs,
horses and non-human primates, in general consistent
with the data from mice; extensive data are also available
from observational studies in humans. Here, we will focus
on the latter, but refer to rodent studies where human data
are lacking or insufficient. Because, despite many similar-
ities, mouse and human immunity can be different, we will
indicate when referring to mouse data instead of human.
Age associated differences in innate immunity in
vertebrates
Phagocytic cells
The first line of immune defence against microbial inva-
sion (Figure 5), apart from physical barrier functionswhich may also degenerate with age but are not really
part of immunity as such, is phagocytosis of pathogens
by neutrophils, macrophages and other cells of this type,
as in invertebrates. Thus, more extensive investigations
of invertebrate models, where confounding factors in-
clude feedback from adaptive immune cells, should be
valuable in researching this under-investigated facet of
immunosenescence. These cells are attracted by factors
released from damaged cells, both host and microbial
components. As well as phagocytic activity, with de-
struction of the invaders by digestion, these first-on-the-
scene defenders trigger inflammatory reactions by
releasing soluble factors with systemic as well as local ef-
fects. It seems that the number and phagocytic capacity
of the most numerous of these, the neutrophils, is rela-
tively well-preserved in elderly people, but certain essen-
tial functions may be compromised [21]. The expression
and function of essential surface receptors recognising
microbe-specific molecules, such as Toll-like receptors,
as well as cytokine production, and expression of other
surface molecules like MHC class II antigens is also re-
duced [22].
Natural killer cells
NK cells (Figure 6) represent a separate lineage of mono-
nuclear lymphocytes which recognise and lyse virus-
infected cells and tumours in an MHC-unrestricted man-
ner and do not form memory, the hallmark of the adaptive
immune response (although recently some memory-like
functions have been ascribed to NK cells under certain
circumstances). Rather little is known about alterations of
NK activity in human ageing, with discrepant reports on
numbers and functions of these cells. A consensus view
could be proposed, that function on a per-cell basis de-
creases but the overall number of NK cells increases as a
compensatory mechanism to maintain an important level
of functionality. The relevance of NK cell activity for
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Figure 5 Age-related changes to the “first-on-the-scene defenders”, such as macrophages and neutrophils. TLR: toll-like receptor; MHC:
major histocompatibility complex.
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function is associated with an increased incidence of infec-
tious diseases and death due to infection in elderly adults
[23]. NK function is probably important also for achieving
a good response to influenza vaccination. Consistent with
the importance of retaining NK function, it seems to be
well-preserved in centenarians.
Dendritic cells
Dendritic cells (DCs) form an essential bridge between
the innate and adaptive immune systems, being respon-
sible for recognising microbial-associated molecules, tak-
ing up and processing pathogen antigens, and presenting





















Figure 6 NK cells and their age-related alterations. NK cell:
natural killer cell; I-2: Interleukin 2; IFN-γ: interferon gamma; TNF-α:
tumor necrosis factor.of DCs, no adaptive immune responses can take place;
moreover, the manner in which the DCs present antigen
controls the type of T cell response achieved, and thus
the quality and intensity of adaptive immune responses.
Peripheral blood is the most accessible source of DCs
for direct analysis or to obtain monocyte-derived DCs.
The numbers of DCs in the elderly may be reduced, and
those present have more mature phenotypes and func-
tions than in the young, consistent with their having
already encountered and been stimulated by antigen.
The numbers of skin DCs, termed Langerhans cells, are
reduced in the elderly, and they seem to be functionally
impaired to some extent. Nonetheless, most studies have
concluded that antigen uptake, processing and presenta-
tion pathways in these innate immune cells appear to be
relatively intact apart from some rather subtle differ-
ences. These include findings that DCs from young and
elderly people stimulate naïve CD8+ T cells equally well,
but those from the elderly may fail to stimulate naïve
CD4+ T cells properly [24]. Some of these changes may
be due to altered proportions of different types of APC
[25], perhaps sufficing to explain the shifts in cytokine
production by DC in the elderly that have been reported
[26]. These would influence the nature of the naïve T
cell response triggered by such DC; altered cytokine pro-
duction by DCs and changes in TLR signalling may be
attributable to altered signal transduction pathways in-
volving phosphoinositide 3-kinase signalling [27] and, in
mice, with reduced phosphorylation of STAT1 and
STAT3 [28]. Failure to induce T cell responses would of
course have grave consequences. For example, it has
been shown in a mouse model that age-associated im-
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Figure 7 Role of dendritic cells and Langerhans cells in immunity and their age-associated changes. NKT cells: natural killer T cells; TLR:
toll-like receptor; PAMP: pathogen-associated molecular pattern; BC: B cell; Ab: antibody; CD8: CD8-positive T cell; Th1: T helper 1 cell; Treg:
regulatory T cell; Th2: T helper 2 cell; IFN-γ: interferon gamma; IL-10: interleukin 10; TGF-β: transforming growth factor beta; IL-4: interleukin 4: IL-5:
interleukin 5; IL-13: interleukin 13.
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associated changes to DCs is limited, but the rather
subtle differences reported could have far-reaching
“knock-on” effects, given that DCs are the central con-
ductors at the innate-adaptive interface and that T cells,
and therefore also B cells, are dependent for their func-
tion on these innate immune cells.
Age-associated differences in adaptive immunity
The adaptive immune response is orchestrated by T cell
interactions with DCs, as alluded to above. T cells
carrying specific receptors for the antigen fragments
presented by DCs must not only be present, they must
be able to respond properly (Figure 8). If the antigen de-
rives from a pathogen not previously encountered, then
naïve cells must be appropriately activated by antigen
and costimulatory ligands on the DCs (eg. CD80, CD86)
for which the T cells must also possess receptors (eg.
CD28). These T cells must then undergo clonal expan-
sion to generate sufficient cells from the limited number
of precursors to mediate effective immune responses, ie.
lysis of infected autologous cells, help for B cells to make
antibody, cytokine and chemokine secretion to regulate
tissue responses, and regulatory elements within the
adaptive immune system to maintain control of ongoing
responses. Thus, if any of these requirements are detri-
mentally affected by ageing, immune responses will be
compromised. Reactivation requirements for re-exposure
of memory cells at a later time point (sometimes decades
later) to the same pathogens are less stringent, requiring
less costimulation and less clonal expansion. Hence they
are faster and more effective than primary responses, and
possibly less susceptible to age-associated detrimental ef-
fects. However, if the primary response had occurred along time ago (for most humans in the wild, this would
have been in childhood), memory cells may be required to
maintain themselves for decades in a host in the absence
of antigen; thus, age-associated deleterious changes in
these cells might also be expected. Clearly, there are many
loci at which age-associated changes could kick in to alter
immune function in the elderly. We will begin by consid-
ering the earliest phase of adaptive immunity, ie. the gen-
eration of naïve cells, which are plentiful in youth but may
become “used up” following pathogen exposure and con-
version to memory cells over the life course.
Thymic involution
Age-associated changes at the level of the hematopoietic
stem cell (HSC) and bone marrow (BM) output reviewed
elsewhere [30] suggest that it is the T and B cell com-
partments of adaptive immunity that are particularly af-
fected, with innate immune components less so (with
the proviso that the more marked changes in adaptive
immunity may be at least in part the result of an amplifi-
cation of the more subtle and more difficult to detect
changes in the latter). Considering the clinical implica-
tions, regardless of whether interventions could be de-
vised, or would then be desirable, to modulate HSC and/
or the stem cell niche and restore youthful patterns of
leukocyte output from the bone marrow, with less mye-
loid and more T and B lymphoid cells, larger numbers of
T cell progenitors produced in this way would not be of
any use unless the thymus retained functionality, and
thymic selection processes were intact. This is because
progenitors exported from the BM must undergo strin-
gent processing in the thymus to generate mature func-
tional naïve T cells (Figure 9). However, for reasons that




















Figure 8 Interaction of T cell and dendritic cell leading to T-cell activation, clonal expansion and differentiation. If any of the activation
requirements are detrimentally affected by ageing, immune responses will be compromised. Additionally, age-related deleterious changes in
memory cells are to be expected. DC: dendritic cells; TC: T cells; Treg: regulatory T cells; CD: cluster of differentiation.
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well before any chronological ageing occurs, ie. as part
of developmental programming, not aging. This is true
for all animals studied so far and thus strongly evolu-
tionarily conserved (including birds, fish and amphibians
as well as mammals) and is often said to be a central
cause of T cell ageing, or immunosenescence. However,
a process beginning during development cannot be con-
sidered as part of an ageing process; rather, reasons for
thymic involution must be sought in developmental













Figure 9 Thymic involution and its consequences for thymopoiesis.reverse a ubiquitous developmental process must be
viewed with extreme caution. Hypotheses to explain
thymic involution remain unproven and have variously in-
voked energetic benefits [31], protection against leukemia
[32], autoimmunity [33] and fine tuning the central posi-
tive T cell selection mechanism in the periphery [34]. Re-
gardless of the reason, the outcome is that the capacity to
produce functional naïve T cells decreases precipitously
with age, starting even before puberty – but, on the other
hand, even very elderly people commonly retain some
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old host, requiring only a small “top-up” of cells already
present in the periphery, and still capable of clonal expan-
sion. It could also be that the nature of the T cells gener-
ated is different in the elderly, as the thymus not only
produces naïve T cells which develop into effector cells,
but also regulatory T cells the targets of which are not
pathogens, but as the name suggests, other T cells and
components of the autologous immune system. Measur-
ing T cell reconstitution after HSC transplantation (usually
for cancer, mostly leukemia) into a depleted host mostly
indicates very little retention of thymic activity in people
aged 40 years or more [36]; but this situation in cancer pa-
tients may not reflect the normal state. Because recent
thymic emigrants (RTEs) are naïve T cells which have not
yet encountered antigen, the presumption has been that
possessing fewer of them must be bad for the host, on
the assumption that the individual’s capacity to resist in-
fection with pathogens previously unencountered will
be compromised. Thus, the elderly are thought to in-
creasingly rely on naïve T cells produced earlier in life
and possibly still present if not stimulated by their cog-
nate antigen, together with the small numbers still being
produced in most older people. Hence, the question can
be justifiably asked whether the elderly do in fact ex-
perience clinical problems as a result of having low
levels of naive T cells. Although this has been assumed,
and because anecdotally the elderly suffer more from in-
fections with emerging pathogens, such as SARS and
West Nile Virus, there are very few systematic data avail-
able to support this contention. One datum supporting
the idea that residual thymic output may indeed be clinic-
ally relevant is implied by a study of mortality in glioma
patients, in which differences in the numbers of recent
thymic emigrants seemed to explain the effect of age on
outcome, but again, the subjects were cancer patients
[37]. In this context, neonatal thymectomy (Figure 10) for
cardiac surgery and the consequent decrease in numbers
of naïve cells as well as other changes seen later in life
[38] would be expected to have negative health conse-
quences too, as has been argued, but again, there is little
hard evidence for this so far. This may be because there is
a general dearth of evidence, and because those children
thymectomized early in life are not yet old enough to suf-
fer the consequences. In any event, longitudinal studies
have shown there appears to be little impact on infections
and health at 1 and 3 years post-thymectomy [39,40], but
this may be much too short a time to see any deleterious
consequences. The situation is further complicated by the
regrowth of the thymus in people theymectomized in in-
fancy, whereby the deficit of naïve cells is minimized [41].
Thus, it remains the case that we have insufficient data
from infant thymectomy to extrapolate to a conclusion
that the decreased levels of naïve T cells often seen inelderly people can definitively be shown to be responsible
for any deleterious clinical events. It is likely that the belief
that vaccines are less effective in the elderly than in the
young is true [42] but most of these are not novel agents
stimulating naïve cells, but rather “booster” vaccines to
agents already encountered or likely to cross-react with
these. This is especially true for the most problematic of
these, influenza, the poor response to which poses a ser-
ious public health problem in the elderly. The same may
be said for shingles, tetanus and so on. These data there-
fore do not prove that fewer naïve cells in the periphery
have a deleterious impact on the health of the elderly be-
cause much of the response would be expected to derive
from memory cells. These considerations, of course, also
raise the question as to whether the efforts of many inves-
tigators to “rejuvenate” thymic function, with its attendant
dangers, might not be misguided and unnecessary. The
above considerations are likely to apply to very elderly,
mostly sessile individuals. However, with increasing activ-
ity and mobility of seniors, problems may emerge in terms
of poor responses to travel vaccines, which would be
expected to require the presence of naïve T cells and func-
tional B cells to provide protection. Studies in this area are
urgently required.
Antigen presentation
For the development of functional immunity, pathogens
must be detected and responded to appropriately. For
this purpose, surface receptors must bind specific ligand
and trigger cell activation only when challenged with
pathogen-derived molecules. As discussed above, the
cells of the innate immune system achieve this by means
of germline-encoded receptors recognizing a limited var-
iety of targets present on micro-organisms but not found
in the host (Figure 1), whereas cells of the adaptive im-
mune system employ highly polymorphic receptors cre-
ated by the random genetic recombination of diverse
elements to assemble recognition units of enormous di-
versity. Antigens derived from pathogens must be taken
up and processed by APC (most usually DCs as men-
tioned above) and presented on the cell surface to T cells
(Figures 2, 7 and 8). It is therefore of paramount import-
ance that both partners in this interaction are functioning
in an optimal manner, both the T cells derived from po-
tentially age-compromized HSCs and processed through a
markedly age-affected thymus before being released to the
periphery (Figure 9).
Immune cell function
T cell function at the population level Experiments
measuring T cell function in the elderly have commonly
revealed marked differences compared with the young:
less proliferative capability and decreased IL 2
Decreased absolute 
CD4+ and CD8+ 
T-cell counts





Increased levels of 
pro-inflammatory 
cytokines
Higher occurrence of 
CMV-seropositivity
Thymectomy 1-3 years post thymectomy 20-40 years post thymectomy? 
?
Figure 10 Premature ageing of the immune system and signs of the immune risk profile in thymectomised patients.
CMV: cytomegalovirus.
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[43]. These findings are commonly interpreted as evi-
dence for decreased immune activity in the elderly, but
may in fact merely reflect the altered proportions of
naïve and memory cells in young and old, ie. a balance
of the state of differentiation of the cell types present, as
a result of previous exposures, or “immunological his-
tory”. In other words, these changes are adaptive. Naïve
cells undergo vigorous clonal expansion involving IL 2
production; late-stage differentiated memory cells do
not. In any experiments aiming to assess T cell status
and function, failure to take this into account will merely
result in a readout of differences in T cell distribution
and functionality at different stages of differentiation
from naïve to activated and memory cell, and the con-
current divergence of these cells along Th1, Th2 and
other pathways (defined by commitment to selective ex-
pression of certain transcription factors, such as Tbet for
Th1 cells, and the resulting cytokine secretion patterns,
such as IFN-γ in the case of Th1 cells). This is of course
important to know, but to compare young and old re-
sponses in the context of age-associated differences, it is
necessary to compare like with like. Differences in the ex-
pression of surface receptors involved in lymphocyte hom-
ing, costimulation, adhesion etc (but not the antigen-
recognising TCR) and in transcription factors determining
T cell lineages, are commonly employed to distinguish
“subsets” of T cells (although they are not actually fixed
subsets in the way that CD4+ T cells and CD8+ T cells
are, but in reality represent different dynamic stages of dif-
ferentiation). According to one widely-employed model,
naïve T cells express homing receptor CC-chemokine re-
ceptor 7 (CCR7) and leukocyte common antigen phos-
phatase isoform CD45RA, and have long telomeres,
whereas many memory T cells express the alternative
splice variant CD45RO, do not express CCR7 and have
shorter telomeres, suggesting an extensive proliferative
history (with lack of telomere maintenance). Isolating
populations of T cells based on these markers assists incomparing like with like in the ageing context, but there is
still the basic problem that we are not dealing with cell
lineages here, but with differentiation stages. These will
differ subtly in different individuals, and represents one of
the many limitations to the most common type of study
in humans, the cross-sectional study (where cohorts of
different ages are compared with one another). This also
makes it difficult to unequivocally identify “senescent”
cells and to discern reliable biomarkers of immune ageing.
However, the best accepted marker in this respect remains
the relative levels of naïve T cells versus memory cells
(which are heterogeneous, with a wide range of pheno-
types and which also exhibit age-related differences in
TCR diversity, telomere lengths and other parameters).
This would be fine except that it is also very difficult to es-
tablish unequivocal markers by which to identify naïve T
cells (and the proviso that we do not know for sure what
clinical relevance low numbers of naïve cells actually has
under most conditions of daily living either in elderly pop-
ulations in industrialized countries or elsewhere). At the T
cell population level, analysing the diversity of the TCR
repertoire may be the most reliable guide to the naïve re-
serve of the individual. To mount an adequate response, a
broad TCR repertoire must be maintained by ensuring the
continuing presence of a diverse population of T-cell
clones in preparation for exposure to completely unantici-
pated new pathogens. Molecular typing of the TCR gene
repertoire, however, indicates that youthful diversity de-
creases with age, even within a particular group of T cells
defined by surface markers as being at the same differenti-
ation stage (“subset”). At least for CD4+ T cells, this has
been reported to occur quite suddenly, with TCR diversity
well maintained up to the age range of 60–65 years, des-
pite the marked decrease of thymic output. However, rep-
ertoire diversity in 75–80 year olds is severely reduced and
is suggested to contribute to poorer defence against infec-
tion in this age group [44]. However, this latter possibility
has not actually been demonstrated and thus also remains
a likely hypothesis still requiring testing. More data of this
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with larger numbers of subjects. One explanation for these
types of changes could be that because T cells are
maintained in a state of constant turnover in the body,
which is either antigen driven or homeostatic (see section
below on lymphocyte dynamics), replicative senescence
(proliferative exhaustion, of the type extremely well-
studied in other cells, especially fibroblasts) can indeed
occur. In cell culture, CD4+ T cells become more suscep-
tible to apoptosis after extensive numbers of cell divisions
[45,46] (Figure 11). The implication of these results is that
by analogy in vivo, CD8+ T cells would accumulate and
CD4+ T cells would be lost, and the CD4+:CD8+ T-cell ra-
tio would therefore change. There is indeed evidence for
the accumulation of CD8+ T cells in vivo, and for their
correlation with poor outcomes to vaccination and with
mortality, as discussed in more detail below. Nonetheless,
the CD4:8 ratio commonly increases, rather than de-
creases, in most elderly people; the relatively rare excep-
tions to this may yield very important information on the
immune status of the individual, putting them into the
“immune risk profile” category [47].
T-cell function at the single-cell level As described
above, to mediate a de novo adaptive immune response,
naïve T cells must be activated by APCs and undergo ex-
tensive clonal expansion to generate sufficient effector
cells to cope with the pathogen, followed by clonal con-
traction and development of memory at resolution of in-
fection. Naïve T cells must therefore divide extensively,
while differentiating into the appropriate balance of
effector cells and memory cells to be retained at reso-
lution of disease. The selection of functional differenti-
ation pathways from naïve cell to numerous functional
T cell populations is determined at this stage (Figure 12).






Figure 11 Accumulation of CD8-positive T cells and loss of CD4-posit
resistance to apoptosis of the respective T-cell subsets.(characterized as expressing the transcription factor Tbet,
resulting in a certain pattern of cytokine gene transcription,
including the hallmark pro-inflammatory cytokine IFN-γ),
Th2 (expressing GATA3 and producing IL-4), Th17 (ex-
pressing RORγ and producing IL-17), regulatory CD4+ T
cells (Tregs, expressing FoxP3 and producing TGF-β), etc.
Alterations in numbers and functional integrity of T cell-
surface receptors, both antigen-specific, and costimulatory,
as well as their location in and transit through the mem-
brane, and their intracellular signalling pathways, would all
be expected to contribute to the final outcome of each T-
cell–APC interaction over the large number of cell divisions
required for a successful immune response. Studies have fo-
cused on alterations in signal transduction as well the for-
mation of signalling domains (such as the immunological
synapse) in a search for mechanisms responsible for any
observed age-related defects in T cell activation. Alterations
to the structure of the TCR or to co-stimulatory receptors
do not appear obvious with advancing age, but their assem-
bly into functional units (“signalosomes”) is probably
compromised. Cell membrane fluidity has a major impact
on TCR mobility and signalosome assembly, as originally
suggested in early studies. The composition of the mem-
brane changes according to systemic fatty-acid availability,
not necessarily as a result of ageing per se. This is an ex-
ample of an important confounding factor which is difficult
to take into account in aging studies in humans, namely
the impact of nutritional variation. Elderly people certainly
differ from the young in their intakes of essentially all nutri-
ents, often being deficient in multiple important compo-
nents, but over-replete in others. The marked effect of the
fatty acid environment was dramatically illustrated by a
seminal study infusing lipids into young volunteers and
measuring rapid alterations to T cell membrane lipid com-
position accompanied by depressed T cell functionality
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Figure 12 T-cell differentiation into functionally different T-cell subsets and age-related defects in T-cell activation. Th1: T helper 1 cells;
Th2: T helper 2 cells; Th17: T helper 17 cells; Tbet, GATA3, ROR, FoxP3: different transcriptional factors; IL: interleukin; TGF-β: transforming growth
factor beta.
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cell signalling as well.
The number and relative proportions of cell surface
receptors mediating co-stimulation are variable according
to differentiation stage of the T cell such that they also
change with age, disease and functional status. Indeed,
decreased or absent expression of one of the well-
studied costimulatory receptors, CD28, was proposed
many years ago as a biomarker for immunosenescence
[49]. This is consistent with findings that late-differentiated
CD8+CD28– T cells tend to accumulate particularly in the
elderly in the immune risk profile group, and because
CD28 expression is lost on in vitro culture prior to CD8 T
cell replicative senescence. However, regulation of CD28
expression is likely to be part of the T cell differentiation
program, rather than necessarily a sign of senescence.
Moreover, CD28 may be up- or downregulated by cyto-
kines such as IL-12 and TNF, respectively, independently of
senescence. Altered signal transduction events in T cells
have been much studied, but it remains unclear to what ex-
tent they are a result of altered proportions of the expressed
positive and negative co-stimulatory receptors, like CD28
and its related negative signalling receptor CD152 (CTLA-
4), or whether altered signal transduction pathways for each
receptor, or both, are most important in determining the
final outcome (ie. activation, anergy or apoptosis). In vitro
studies on clonal cultured T cell populations may allow us
to distinguish between changes caused by altered propor-
tions of cell subsets and changes within the same clones at
different times, eg. in the expression of the receptors al-
luded to above. Even for TCR signalling itself, differencesbetween young and old donors´ naïve and memory T cells,
or between CD4+ and CD8+ T cells, are not yet sufficiently
well delineated.
B cell function In addition to the commonly decreased
numbers of peripheral B cells in the elderly, especially
those in the IRP group, age-associated changes to B cells
and their subsets are also observed. These are less-well
studied than in T cells, but like T cells, memory B cells
do most likely accumulate with age, although data from
different studies are discordant [50]. One reason for dis-
crepancies might reside in the application of the markers
identifying memory cells; as with T cells, it is differenti-
ation states and not really subsets that are being mea-
sured [51]. At the functional level, age-associated
alterations in immunoglobulin generation during im-
mune responses have been reported, both via Ig class
switching and somatic hypermutation [52]. This could
be one mechanism accounting for the decline of the
quality of humoral responses in the elderly. Further data
on B cell alterations are needed, particularly since de-
creased absolute numbers of B cells may be associated
with earlier mortality in longitudinal studies of the very
elderly.
Immune cell turnover As discussed above, thymic out-
put of naïve T cells is greatly decreased in older people,
and often assumed to be negligible; nonetheless, in
healthy elderly donors, peripheral T cell homeostasis is
generally well maintained so that numbers of circulating
T cells remain constant. How can this be accomplished?
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naïve T cells, but rather, the peripheral expansion of pre-
existing T cells. Experiments to assess T cell dynamics
are difficult in humans, but one pioneering approach ex-
ploits the incorporation of deuterated glucose into divid-
ing lymphocytes (T cells, B cells and NK cells) to track
their turnover. In naïve, memory and regulatory T-cells,
glucose uptake and its subsequent loss occurs rapidly.
Interestingly, it is the regulatory T cells that appear to
proliferate the most rapidly [53]. One major important
age-associated difference is that CD8+ memory cells in
the elderly cycle considerably more slowly than any
other subset, but this is not the case in young donors.
This finding is consistent with the noted accumulation
of CD8 memory cells in old people, since they may not
reach a state of replicative senescence so quickly and are
apoptosis-resistant [54], whereas the opposite is true of
CD4+ T cells. B cells also showed some differences, but
in this case it was the memory B cells that turned over
more rapidly than the naïve cells. For NK cells, produc-
tion and proliferation rates were lower in the elderly
than in the young, which may also be relevant to the
finding mentioned above that NK status is important for
healthy ageing and infection resistance [23].
Because of the rapid T-cell turnover revealed by these
studies, and given the Hayflick limit to the number of
cell divisions normal somatic cells can undertake before
senescence, it would be predicted that the proliferative
capacity of the individual T cell clones constituting the
response would eventually become exhausted [55]. Espe-
cially CD8 cells at this late stage express a highly differ-
entiated phenotype (CD27 and CD28-negative, short
telomeres, lack of telomerase and expression of negative
signalling receptors like PD-1, CD57 and KLRG-1) [56].
In analogy with so-called replicatively senescent fibro-
blasts with altered cytokine secretion patterns, late-stage
memory T-cells may also acquire new functions such as
suppressive activity as previously demonstrated in vitro a
decade earlier [57]. The mechanisms by which such
“exhausted” cells suppress may include competition for
cytokines or antigen on the DC surface, altered cytokine
secretion patterns, or acquisition of cytotoxicity. At this
stage, chronic stimulation by the original antigen itself is
probably no longer necessary to keep the cells constantly
turning over; hence memory T cells can persist for a life-
time, long after antigen exposure, even in the absence of
persistent infection or periodic re-infection. Turnover
may be supported by cytokines released by other cells
reacting to completely different antigens (the so-called
“bystander” effect). Thus, T-cell clonal exhaustion could
be said to be an intrinsic characteristic of adaptive immun-
ity, continuing even in the absence of specific chronic in-
fection. However, in natural human populations, and even
in sanitized Western societies, certain chronic infections orsome other infections are always likely to be present. In
every country studied so far, commonly persistent “asymp-
tomatic” viruses and other pathogens which co-exist usu-
ally in a peaceful (perhaps even mutually beneficial?)
association with the host are found. One of these, the beta-
herpesvirus HHV5 (Cytomegalovirus, CMV), stands out
from the rest as a common driving force for the observed
age-associated immune alterations. Of course, this does
not exclude the possibility that in different environments
where CMV is less prevalent (should there be any, since
CMV appears endemic in humans, and not being infected
with it may actually be an artefact of civilisation), or for
other reasons, other pathogens may play a similar role.
Some similar phenomena linked to T cell clonal exhaus-
tion, senescence and suppression may also occur in many
disease states, such as in HIV infection, cancer and auto-
immunity, in all of which different sources of antigen could
act as a chronic immune stimulant. Thus, we would argue
that age itself may not influence peripheral senescence
events directly, but acts indirectly via the impact of differ-
ential pathogen loads and different durations of infection
to exhaust the mature immune system [58]. In the absence
of large-scale production of naïve T cells as a consequence
of thymic involution and the limited capacity of the periph-
eral “immunological space” to absorb the accumulating
memory cells, adaptive immunity becomes progressively
compromised.
Conclusions
Studying immunity in model organisms can be informative
for determining the effects of age and might point the way
to seeking previously unsuspected age-associated alter-
ations in certain components of the human immune system
otherwise obscured by the complexity of the whole. How-
ever, this is manifestly true only for components of innate
immunity. The greater susceptibility to immunosenescence
of the adaptive arm of immunity relative to the innate arm
is suggested to be due to the necessity of maintaining clonal
expansions of memory cells unable to self-renew in the way
that innate immune cells can. This is the price paid for a
much larger receptor repertoire of adaptive compared to
innate immune cells, which in turn may be required to
maintain homeostasis of the gut microbiota, keeping patho-
gens at bay while not reacting to the majority of symbionts.
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